Technical Analysis for ABMD - ABIOMED, Inc.

Grade Last Price % Change Price Change
grade A 305.92 -0.17% -0.53
ABMD closed down 0.17 percent on Friday, April 20, 2018, on 63 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: May 3

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ABMD trend table...

Date Alert Name Type % Chg
Apr 20 Outside Day Range Expansion 0.00%
Apr 20 Overbought Stochastic Strength 0.00%
Apr 19 Narrow Range Bar Range Contraction -0.17%
Apr 19 NR7 Range Contraction -0.17%
Apr 19 Inside Day Range Contraction -0.17%
Apr 19 Overbought Stochastic Strength -0.17%
Apr 18 New 52 Week Closing High Bullish -0.56%
Apr 18 New 52 Week High Strength -0.56%
Apr 18 Upper Bollinger Band Walk Strength -0.56%
Apr 18 Above Upper BB Strength -0.56%

Older signals for ABMD ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Is ABMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 309.28
52 Week Low 123.6
Average Volume 433,687
200-Day Moving Average 204.4325
50-Day Moving Average 281.1982
20-Day Moving Average 293.1545
10-Day Moving Average 299.923
Average True Range 8.4347
ADX 20.28
+DI 25.3
-DI 14.59
Chandelier Exit (Long, 3 ATRs ) 283.9759
Chandelier Exit (Short, 3 ATRs ) 299.5341
Upper Bollinger Band 310.692
Lower Bollinger Band 275.617
Percent B (%b) 0.86
BandWidth 11.964681
MACD Line 6.9439
MACD Signal Line 6.1934
MACD Histogram 0.7505
Fundamentals Value
Market Cap 13.5 Billion
Num Shares 44.1 Million
EPS 1.71
Price-to-Earnings (P/E) Ratio 178.90
Price-to-Sales 16.68
Price-to-Book 13.96
PEG Ratio 2.75
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 312.54
Resistance 3 (R3) 312.20 309.66 311.43
Resistance 2 (R2) 309.66 307.98 309.83 311.06
Resistance 1 (R1) 307.79 306.93 306.52 308.13 310.70
Pivot Point 305.25 305.25 304.62 305.42 305.25
Support 1 (S1) 303.38 303.57 302.11 303.72 301.14
Support 2 (S2) 300.84 302.52 301.01 300.78
Support 3 (S3) 298.97 300.84 300.41
Support 4 (S4) 299.31